Integrum AB (publ)
INTEG-B
Rank in Stocks
#25856
Integrum AB (publ) focuses on the research, development, and global sale of... Integrum AB (publ) focuses on the research, development, and global sale of advanced bone-anchored prosthetic solutions. A core offering is the Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant system. This innovative bone-anchored prosthesis integrates directly with the patient's bone through osseointegration, thus circumventing the need for a conventional socket. A significant benefit of the OPRA system is its protective quality, helping to prevent bone fractures from accidental loads. Additionally, Integrum provides Neuromotus, a therapeutic technology designed to mitigate phantom limb pain following an amputation. These sophisticated implant systems are distributed worldwide to hospitals, clinics, and orthopedic professionals. The company was founded in 1962 and is based in Mölndal, Sweden.
Share Price
$0.82029017
Last synced: 2026-11-09
Market Cap
$23.54M
Change (1 day)
0.54%
Change (1 year)
-7.96%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Integrum AB (publ) (INTEG-B)
Category
Healthcare
EPS for Integrum AB (publ) (INTEG-B)
EPS as of July 2026 TTM: $-0.15
According to Integrum AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.15. At the end of 2025 the company had an EPS of $-0.15, a decrease compared to its 2024 EPS of $0.02.
EPS history for Integrum AB (publ) from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.15 | -3.13% |
| 2025 | $-0.15 | -817.22% |
| 2024 | $0.02 | -124.39% |
| 2023 | $-0.09 | -170.19% |
| 2022 | $0.12 | -835.54% |
| 2021 | $-0.02 | -84.41% |
| 2020 | $-0.11 | -48.40% |
| 2019 | $-0.21 | -2.41% |
| 2018 | $-0.21 | 192.13% |
| 2017 | $-0.07 | 5,469.23% |
| 2016 | 0.00 | 0.00% |
| 2015 | 0.00 | -100.00% |
| 2014 | $0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -1,958.22% |
US
|
|
| $4.09 | -2,914.87% |
IE
|
|
| $9.45 | -6,603.79% |
US
|
|
| $2.37 | -1,731.11% |
US
|
|
| $1.77 | -1,318.17% |
US
|
Questions about Integrum AB (publ)'s earnings per share (EPS)
What is Integrum AB (publ)'s earnings per share (EPS)?
Integrum AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.15, as of Jul 2026.
What was Integrum AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Integrum AB (publ)'s earnings per share (EPS) was $-0.15, compared with $0.02 in 2024.
How has Integrum AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Integrum AB (publ)'s earnings per share (EPS) was highest in 2022 ($0.12) and lowest in 2025 ($-0.15).
How does Integrum AB (publ)'s earnings per share (EPS) compare with similar companies?
Integrum AB (publ)'s earnings per share (EPS) ($-0.15) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.